- Background
- What we're looking for
- What we can offer you
- Q&A
We are seeking subject matter experts with tools, methods, or expertise that can help identify FDA-approved compounds with UV-blocking capacity, individually or in combination, to accelerate innovation in sun protection.
Background
We are a major player and market leader in the consumer health & beauty industry, with a portfolio that spans multiple channels, demographics, and categories.
Despite the high demand for innovative sun protection products, regulatory hurdles remain a major challenge. Only a limited number of sunscreen actives are FDA-approved, and the complex process to approve new ones can take years. To accelerate innovation, we are interested in exploring the potential of compounds that are already FDA-approved for other uses and may also have UV-blocking properties. This approach could create a regulatory bridge, shorten development timelines, expand the palette of active ingredients, and reduce the barriers for bringing new sun care solutions to market.
What we're looking for
We are looking for experts who can bring tools, methods, or insights to identify and evaluate FDA-approved compounds that could act as UV-blockers, either individually or in synergistic combinations. This could include computational screening approaches, dermatological insights into compound performance, formulation knowledge to assess compatibility and effectiveness, or other analytical tools to identify candidates for repurposing. We are open to regulatory consultants, formulators, materials chemists, dermatologists, toxicologists, photobiologists, and computational scientists who can contribute to the detection and validation of UV-blocking potential in FDA-approved materials.
Screening FDA-approved compounds for UV-absorbing, scattering, or protective properties
Computational screening approaches (in silico, database-driven, predictive modeling)
Translating compound identification into potential sunscreen applications
Methods for evaluating synergistic effects among multiple FDA-approved compounds
Regulatory considerations for repurposing FDA-approved compounds for sun care applications
Familiarity with FDA-approved material lists relevant to consumer products
Expertise, tools, or methods (e.g., computational screening, regulatory databases, cheminformatics) that could assist in detecting UV-blocking potential in FDA-approved compounds
Experience in sunscreen formulation, dermal delivery systems, or topical consumer products
Dermatological expertise in evaluating UV protection or skin safety
Familiarity with consumer product development in skin health or sun care
Regulatory experience only in non-FDA jurisdictions (e.g., EU, Japan, Australia)
Sole focus on formulation without expertise in identifying UV-blocking candidates
Approaches limited to developing entirely new, non-approved molecules
- Accepting applications from experts based in all countries
What we can offer you
The Q&A is now closed.
Other recommended requests
delivered to your inbox.